Exomnis Biotech

Over Exomnis Biotech

Exomnis Biotech is a Maastricht based start-up company, operating at the intersection of microbiology, engineering and immunology. As a spin-off from Maastricht University, taking advantage of more than 100 years combined experience, we have developed engineered commensal bacteria as “living medicines” with a first focus on immuno-therapeutics for cancer treatments.

Our solution employs forefront synthetic biology techniques to genetically engineer anaerobic, spore-forming bacteria (Clostridium Sporogenes) with CRISPR-Cas9 gene editing and allelic exchange technology. These plasmid and antibiotic-free spores become delivery vehicles that secret therpautics only at the core of hypoxic/necrotic tumours.

Trefwoorden

• Clostridium Sporogenes
• Immunotherapy
• Pharma Contract Service
• Smart Bacteria Based Drug Delivery System
• Viral Infection Vaccination Delivery

Team per functiegebied

Gebaseerd op 1 openbare functieprofielen, stand van 19 september 2026.

• Executive / C-Suite1